ArticleHaematologica2022

Older patients (aged ≥60 years) with previously untreated advanced-stage classical Hodgkin lymphoma: a detailed analysis from the phase III ECHELON-1 study.

Andrew M Evens et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.